Role of heparanase in ARDS through autophagy and exosome pathway (review)

• Published in: Frontiers in pharmacology Vol. 14; p. 1200782
• Main Authors: Feng, Fei, Wang, Lin-Jun, Li, Jian-Chun, Chen, Ting-Ting, Liu, Liping
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 08.06.2023
• Subjects: ARDS; coagulation; exosome; fibrosis; heparinase; inflammation; Pharmacology; autophagy; heparinase; inflammation; fibrosis; coagulation; exosome; ARDS
• ISSN: 1663-9812; 1663-9812
• DOI: 10.3389/fphar.2023.1200782

Acute respiratory distress syndrome (ARDS) is the most common respiratory disease in ICU. Although there are many treatment and support methods, the mortality rate is still high. The main pathological feature of ARDS is the damage of pulmonary microvascular endothelium and alveolar epithelium caused by inflammatory reaction, which may lead to coagulation system disorder and pulmonary fibrosis. Heparanase (HPA) plays an significant role in inflammation, coagulation, fibrosis. It is reported that HPA degrades a large amount of HS in ARDS, leading to the damage of endothelial glycocalyx and inflammatory factors are released in large quantities. HPA can aggrandize the release of exosomes through syndecan-syntenin-Alix pathway, leading to a series of pathological reactions; at the same time, HPA can cause abnormal expression of autophagy. Therefore, we speculate that HPA promotes the occurrence and development of ARDS through exosomes and autophagy, which leads to a large amount of release of inflammatory factors, coagulation disorder and pulmonary fibrosis. This article mainly describes the mechanism of HPA on ARDS.